top | item 24568163

(no title)

mquirion | 5 years ago

I almost never comment, but the answer here is simple: markets.

The common cold doesn't kill. There's almost no economic impetus for a cure. Note, I said "almost." There may be some, but there's still not enough to drive R&D in a corporate lab, and certainly not enough to drive policy in a government lab.

There are 100 other questions that would follow from science to logistic once you answer: Can we create a drug that kills infection in clinical tests?

discuss

order

epmaybe|5 years ago

Cold can kill, viral pneumonia is real as our current pandemic can attest to. There's certainly a market to cure all sorts of viral illness. Take tamiflu as an example. Most people if they get a flu will use it once a year to reduce symptoms. Imagine a drug that would reduce all symptoms of cold that you take every time you get cold symptoms. That's potentially billions of dollars in revenue each year.

throwmeaway_pls|5 years ago

NyQuil’s and Alka Seltzer’s sales figures beg to differ.

mquirion|5 years ago

NyQuil and Alka Seltzer would beg you not to kill the cash cows.

Plus NyQuil and AS can be produced and sold in such a way as to net a profit. We don't know that's the case for a cold cure.

karlshea|5 years ago

Those aren’t cures.

lm28469|5 years ago

You'll make much more money selling symptoms relievers every years than fixing the issue once and for all.

Enginerrrd|5 years ago

Those both work against symptoms caused by an enormous range of pathologies though.

Compare that to a specific drug targeting a small percentage of the causative agents of the common cold, for which the duration is short enough that by the time you'd get a reliable test back, you'd have gotten over your cold anyway.

There's just not much of a practical use for such a drug.

fiftyfifty|5 years ago

I would actually argue that it should be the government's role to push the development of vaccines and drugs for treating even harmless diseases. We spend trillions of dollars on national defense in the US, when you look at the economic damage and cost in lives that the Covid-19 outbreak has cost us, the threat of disease outbreaks is every bit as damaging as a military attack, maybe even worse. If we had taken the time to develop and take all the way through the approval process a vaccine to previously encountered Coronaviruses such as SARS or MERS we would probably already have a vaccine against SARS-CoV-2 approved by the FDA and in distribution. Maybe we should be building a few less F-35s and instead be developing vaccines against otherwise harmless viruses, because you never know when a close relative of a harmless virus is going to turn into a deadly outbreak. In the US at least that seems like it should fall under the protective role of the federal government.

jokethrowaway|5 years ago

The economic damage is coming mainly from economical policies, namely lockdowns. The death rate has been quite low overall, even including the initial phase in which our incompetence in curing covid caused more deaths than it should have.

I agree the government wastes money on a lot of things (13bln per day!) and that's exactly why I'd rather have the market come up with what we should be spending our money on.

newsbinator|5 years ago

Surely there's a Nobel Prize in it though?